Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Abstract The evolution of diagnosis and treatment of advanced nonsmall‐cell lung cancer (NSCLC) has led to increasing the use of targeted therapy and immune checkpoint inhibitors. The study goal was to assess the effect of molecular testing and the introduction of new therapies on overall survival (...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Aria Shokoohi, Zamzam Al‐Hashami, Sara Moore, Alexandra Pender, Selina K. Wong, Ying Wang, Bonnie Leung, Jonn Wu, Cheryl Ho
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2022-01-01
Schriftenreihe:	Cancer Medicine
Schlagworte:	chemotherapy immunotherapy medical oncology nonsmall‐cell lung cancer targeted therapy
Online-Zugang:	https://doi.org/10.1002/cam4.4427
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!